Eupraxia Pharmaceuticals, Inc. (EPRX)
6.65
+0.05
(+0.76%)
USD |
NASDAQ |
Nov 06, 09:59
Eupraxia Pharmaceuticals Market Cap : 435.40M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 432.13M |
| November 04, 2026 | 442.61M |
| November 03, 2026 | 450.46M |
| November 02, 2026 | 442.61M |
| October 30, 2026 | 447.19M |
| October 29, 2026 | 474.69M |
| October 28, 2026 | 483.20M |
| October 27, 2026 | 463.56M |
| October 26, 2026 | 448.50M |
| October 23, 2026 | 449.81M |
| October 22, 2026 | 496.95M |
| October 21, 2026 | 506.12M |
| October 20, 2026 | 496.95M |
| October 19, 2026 | 455.05M |
| October 16, 2026 | 433.44M |
| October 15, 2026 | 443.26M |
| October 14, 2026 | 431.48M |
| October 13, 2026 | 437.37M |
| October 12, 2026 | 479.27M |
| October 09, 2026 | 488.44M |
| October 08, 2026 | 495.64M |
| October 07, 2026 | 509.39M |
| October 06, 2026 | 506.77M |
| October 05, 2026 | 507.10M |
| October 02, 2026 | 474.03M |
| Date | Value |
|---|---|
| October 01, 2026 | 512.66M |
| September 30, 2026 | 595.82M |
| September 29, 2026 | 543.76M |
| September 28, 2026 | 537.54M |
| September 25, 2026 | 524.45M |
| September 24, 2026 | 534.27M |
| September 23, 2026 | 532.96M |
| September 22, 2026 | 561.77M |
| September 21, 2026 | 565.70M |
| September 18, 2026 | 561.77M |
| September 17, 2026 | 548.67M |
| September 16, 2026 | 529.69M |
| September 15, 2026 | 531.00M |
| September 14, 2026 | 528.38M |
| September 11, 2026 | 551.29M |
| September 10, 2026 | 525.10M |
| September 09, 2026 | 529.03M |
| September 08, 2026 | 540.16M |
| September 04, 2026 | 549.98M |
| September 03, 2026 | 491.06M |
| September 02, 2026 | 487.78M |
| September 01, 2026 | 415.11M |
| August 31, 2026 | 422.96M |
| August 28, 2026 | 437.04M |
| August 27, 2026 | 481.89M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Edesa Biotech, Inc. | 20.52M |
| ProMIS Neurosciences, Inc. | 37.22M |
| Arrowhead Pharmaceuticals, Inc. | 8.125B |
| Oncolytics Biotech, Inc. | 56.65M |
| Sangamo Therapeutics, Inc. | 47.23M |
Market Cap Related Metrics
| PEG Ratio | -0.4112 |
| Price to Book Value | 4.279 |
| Price | 6.65 |
| Earnings Yield | -14.81% |
| PEGY Ratio | -0.4112 |